Company Analysis

Jaguar Health, Inc. (JAGX)

Nasdaq: JAGX · Pharmaceutical Preparations · San Francisco, CA · filing with the SEC since 2013
Grade3.9
◀ Past 2.9● Present 4.4▶ Future 4.0
1 est.

Who runs Jaguar Health, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Officers reporting now
5
of 9 people with a filing in the last fifteen months
Directors reporting now
4
19 people on the record since 2015
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Conte Lisa AChief Exec. Officer & PresidentMay 2015Jan 21, 2026none
King Steven R.Chief of Sustainable Supply, Ethnobotanical Research and Intellectual Property and SecretaryMay 2015Jan 21, 2026none
Wolin Jonathan S.Chief of Staff, Chief Compliance Officer & General CounselSep 2019Jan 21, 2026none
Lizak Carol R.Chief Financial OfficerAug 2019Dec 15, 2025none
Chaturvedi Pravin RChief Scientific OfficerMar 2022Dec 15, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Micek JohndirectorApr 2016Mar 12, 2026none
Bochnowski James JdirectorMay 2015Dec 15, 2025none
Jayasuriya AnuladirectorJul 2022Dec 15, 2025none
Siegel Jonathan B.directorApr 2018Dec 15, 2025none
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Lincoln Alternative Strategies LLC10% ownerAug 2025Aug 29, 2025none
Earlier names on the record18, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton JAGX · research, not advice